A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy
Clinical trial NCT05612178 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05612178
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2027-03-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.